BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30676661)

  • 1. Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human.
    Wong YC; Centanni M; de Lange ECM
    J Clin Pharmacol; 2019 May; 59(5):731-747. PubMed ID: 30676661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a population pharmacokinetic model to predict brain distribution and dopamine D2 receptor occupancy of raclopride in non-anesthetized rat.
    Wong YC; Ilkova T; van Wijk RC; Hartman R; de Lange ECM
    Eur J Pharm Sci; 2018 Jan; 111():514-525. PubMed ID: 29106979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
    Olsen CK; Brennum LT; Kreilgaard M
    Eur J Pharmacol; 2008 Apr; 584(2-3):318-27. PubMed ID: 18325493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats.
    Kozielska M; Johnson M; Pilla Reddy V; Vermeulen A; Li C; Grimwood S; de Greef R; Groothuis GM; Danhof M; Proost JH
    Pharm Res; 2012 Jul; 29(7):1932-48. PubMed ID: 22437487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational Modeling in Schizophrenia: Predicting Human Dopamine D2 Receptor Occupancy.
    Johnson M; Kozielska M; Pilla Reddy V; Vermeulen A; Barton HA; Grimwood S; de Greef R; Groothuis GM; Danhof M; Proost JH
    Pharm Res; 2016 Apr; 33(4):1003-17. PubMed ID: 26718955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics.
    Li CH; Stratford RE; Velez de Mendizabal N; Cremers TI; Pollock BG; Mulsant BH; Remington G; Bies RR
    J Transl Med; 2014 Aug; 12():203. PubMed ID: 25142323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of CNS occupancy of dopamine D2 receptor based on systemic exposure and in vitro experiments.
    Kanamitsu K; Arakawa R; Sugiyama Y; Suhara T; Kusuhara H
    Drug Metab Pharmacokinet; 2016 Dec; 31(6):395-404. PubMed ID: 27745731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach.
    Johnson M; Kozielska M; Pilla Reddy V; Vermeulen A; Barton HA; Grimwood S; de Greef R; Groothuis GM; Danhof M; Proost JH
    Pharm Res; 2014 Oct; 31(10):2605-17. PubMed ID: 24792824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of maintenance therapy of Risperidone with CYP2D6 genetic polymorphisms through an extended translational framework-based prediction of target occupancies/clinical outcomes.
    Li HQ; Xu JY; Gao YY; Jin L
    Pharmacol Res; 2018 Nov; 137():135-147. PubMed ID: 30281999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat.
    Shimizu S; den Hoedt SM; Mangas-Sanjuan V; Cristea S; Geuer JK; van den Berg DJ; Hartman R; Bellanti F; de Lange EC
    Drug Metab Dispos; 2017 Feb; 45(2):152-159. PubMed ID: 27836941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats.
    Johnson M; Kozielska M; Pilla Reddy V; Vermeulen A; Li C; Grimwood S; de Greef R; Groothuis GM; Danhof M; Proost JH
    Pharm Res; 2011 Oct; 28(10):2490-504. PubMed ID: 21647790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics.
    Takano A; Suhara T; Ikoma Y; Yasuno F; Maeda J; Ichimiya T; Sudo Y; Inoue M; Okubo Y
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):19-26. PubMed ID: 14764214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of prolactin response following dopamine D
    Taneja A; Vermeulen A; Huntjens DRH; Danhof M; De Lange ECM; Proost JH
    Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P; Tallerico T
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.
    Muly EC; Votaw JR; Ritchie J; Howell LL
    J Pharmacol Exp Ther; 2012 Apr; 341(1):81-9. PubMed ID: 22214649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two semi-mechanistic models for prolactin release and prediction of receptor occupancy following administration of dopamine D2 receptor antagonists in rats.
    Taneja A; Vermeulen A; Huntjens DRH; Danhof M; De Lange ECM; Proost JH
    Eur J Pharmacol; 2016 Oct; 789():202-214. PubMed ID: 27395799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial.
    Nakajima S; Uchida H; Bies RR; Caravaggio F; Suzuki T; Plitman E; Mar W; Gerretsen P; Pollock BG; Mulsant BH; Mamo DC; Graff-Guerrero A
    Schizophr Bull; 2016 Jan; 42(1):212-9. PubMed ID: 26221049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes.
    Kneller LA; Abad-Santos F; Hempel G
    Clin Pharmacokinet; 2020 Jan; 59(1):51-65. PubMed ID: 31359271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Pharmacology of Risperidone and Paliperidone.
    Corena-McLeod M
    Drugs R D; 2015 Jun; 15(2):163-74. PubMed ID: 25943458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.